lobbying_activities: 1668326
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1668326 | 87d0e26e-ada2-494d-b971-f284f8736e60 | Q1 | BROWN RUDNICK LLP | 287895 | EXELA HOLDINGS, LLC | 2015 | first_quarter | PHA | Issues relating to ANDA review and approval | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-17T14:46:01.703000-04:00 |